Glucose Oxidase-Based Glucose-Sensitive Drug Delivery for Diabetes Treatment
AbstractThe glucose-sensitive drug delivery systems based on glucose oxidase (GOD), which exhibit highly promising applications in diabetes therapy, have attracted much more interest in recent years. The self-regulated drug delivery systems regulate drug release by glucose concentration automatically and continuously to control the blood glucose level (BGL) in normoglycemic state. This review covers the recent advances at the developments of GOD-based glucose-sensitive drug delivery systems and their in vivo applications for diabetes treatment. The applications of GOD-immobilized platforms, such as self-assembly layer-by-layer (LbL) films and polymer vesicles, cross-linking hydrogels and microgels, hybrid mesoporous silica nanoparticles, and microdevices fabricated with insulin reservoirs have been surveyed. The glucose-sensitive drug delivery systems based on GOD are expected to be a typical candidate for smart platforms for potential applications in diabetes therapy. View Full-Text
Share & Cite This Article
Zhao, L.; Wang, L.; Zhang, Y.; Xiao, S.; Bi, F.; Zhao, J.; Gai, G.; Ding, J. Glucose Oxidase-Based Glucose-Sensitive Drug Delivery for Diabetes Treatment. Polymers 2017, 9, 255.
Zhao L, Wang L, Zhang Y, Xiao S, Bi F, Zhao J, Gai G, Ding J. Glucose Oxidase-Based Glucose-Sensitive Drug Delivery for Diabetes Treatment. Polymers. 2017; 9(7):255.Chicago/Turabian Style
Zhao, Li; Wang, Liyan; Zhang, Yuhan; Xiao, Shanshan; Bi, Fei; Zhao, Jianyu; Gai, Guangqing; Ding, Jianxun. 2017. "Glucose Oxidase-Based Glucose-Sensitive Drug Delivery for Diabetes Treatment." Polymers 9, no. 7: 255.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.